XML 24 R14.htm IDEA: XBRL DOCUMENT v3.22.4
Stockholders' Equity
9 Months Ended
Jan. 31, 2023
Equity [Abstract]  
Stockholders' Equity Stockholders’ Equity
Share Repurchases
On June 20, 2022, the Company's Board of Directors approved an expanded share repurchase program under which the Company is authorized to repurchase up to $200.0 million of its outstanding common stock. This expanded program replaced the Company’s previous share repurchase authorization of $75.0 million. The Company may conduct repurchases under the share repurchase program through open market transactions, under trading plans in accordance with SEC Rule 10b5-1 and/or in privately negotiated transactions, in each case in compliance with Rule 10b-18 under the Securities Exchange Act of 1934, as amended. The timing and amount of any purchases of the Company's common stock are subject to a variety of factors, including, but not limited to, the Company’s liquidity, credit availability, general business and market conditions, debt covenants and the availability of alternative investment opportunities. The share repurchase program does not obligate the Company to acquire any amount of common stock, and it may be suspended or terminated at any time at the Company’s discretion.
The Company repurchased approximately 1.8 million shares of its common stock for $82.8 million during the nine months ended January 31, 2023, of which $10.8 million was repurchased under the previous authorization and $72.0 million was repurchased under the new authorization. The Company repurchased approximately 0.4 million shares of its common stock for $17.9 million during the nine months ended January 31, 2022. As of January 31, 2023, the Company had $128.0 million of remaining repurchase authorization under its stock repurchase program. 
Accumulated Other Comprehensive Loss
The following table sets forth the changes to accumulated other comprehensive loss, net of tax, by component for the nine months ended January 31, 2023:
Foreign
Currency
Translation
Derivative
Financial
Instruments
Accumulated
Other
Comprehensive
Loss
(in thousands)
Balance as of April 30, 2022$(5,041)$(1,002)$(6,043)
Other comprehensive income (loss) before reclassification(21,728)957 (20,771)
Reclassification to earnings from accumulated other comprehensive loss512 512 
Balance as of January 31, 2023$(26,769)$467 $(26,302)
Other comprehensive income (loss) before reclassification on derivative instruments for the nine months ended January 31, 2023 is net of $0.3 million of tax. Reclassification to earnings from accumulated other comprehensive loss is net of $0.2 million of tax.